Helicobacter pylori
Typical setting: Chronic gastric infection, often acquired earlier in life.
Inflammation, urease activity, and altered acid regulation weaken mucosal defence and promote ulceration.
PUD module
Understand peptic ulcer disease as acid-pepsin injury overcoming mucosal defence, commonly from H. pylori or NSAIDs, causing pain, bleeding, perforation, and obstruction risk.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Ulcers develop when acid-pepsin injury overcomes mucosal protection.
Typical setting: Chronic gastric infection, often acquired earlier in life.
Inflammation, urease activity, and altered acid regulation weaken mucosal defence and promote ulceration.
Typical setting: Ibuprofen, naproxen, diclofenac, aspirin, or combined ulcer-risk drugs.
Prostaglandin inhibition reduces mucus, bicarbonate, blood flow, and repair.
Typical setting: Critical illness, burns, head injury, shock, ventilation, or coagulopathy.
Mucosal hypoperfusion and stress-related acid injury increase ulcer risk.
Typical setting: Rare causes such as gastrinoma.
Very high acid output overwhelms duodenal neutralisation and mucosal defence.
Typical setting: NSAIDs with steroids, anticoagulants, antiplatelets, older age, or previous ulcer.
Mucosal injury and impaired haemostasis increase severe bleeding risk.
Mechanism chain
The ulcer forms when defence fails at the surface and injury extends deeper.
H. pylori inflammation or NSAID-related prostaglandin loss reduces mucus, bicarbonate, blood flow, and repair.
The protective surface barrier no longer keeps acid-pepsin injury away from epithelial cells.
Keep exploring